학술논문

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Document Type
Article
Source
In: Vaccines. (Vaccines, February 2023, 11(2))
Subject
Language
English
ISSN
2076393X